![]()
|
|
||||||||
(Received for publication, February 6, 1996)
From the Department of Cardiology, Children's Hospital, and
§ Department of Cell Biology and Pediatrics, Harvard
Medical School, Boston, Massachusetts 02115
The mammalian achaete-scute homolog 1 (MASH1)
protein is required for the early development of the nervous system.
However, the molecular and biochemical mechanism by which MASH1 acts to
determine neurogenesis are still unknown. The myocyte enhancer factor
2A (MEF2A) is a MADS transcription factor that is essential for the
specification and differentiation of the muscle lineage. Here we show
that MEF2A and MASH1 are coordinately induced during the
differentiation of the teratocarcinoma cell line P19 along a neuronal
lineage and that in transient transfection assays, MEF2A and MASH1
cooperatively activate gene expression. This cooperativity appears to
be due to a specific physical interaction between MEF2A and MASH1.
Taken together, these findings suggest that MASH1 via a cooperative
interaction with MEF2A may regulate the expression of specific genes
that are critical for neuronal differentiation.
This article has been cited by other articles:
![]() |
Z. Li, S. R. McKercher, J. Cui, Z. Nie, W. Soussou, A. J. Roberts, T. Sallmen, J. H. Lipton, M. Talantova, S.-i. Okamoto, et al. Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem Cells J. Neurosci., June 25, 2008; 28(26): 6557 - 6568. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morin, G. Pozzulo, L. Robitaille, J. Cross, and M. Nemer MEF2-dependent Recruitment of the HAND1 Transcription Factor Results in Synergistic Activation of Target Promoters J. Biol. Chem., September 16, 2005; 280(37): 32272 - 32278. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, C. Fan, S. E. Topol, E. J. Topol, and Q. Wang Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease Science, November 28, 2003; 302(5650): 1578 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bolouri and E. H. Davidson Transcriptional regulatory cascades in development: Initial rates, not steady state, determine network kinetics PNAS, August 5, 2003; 100(16): 9371 - 9376. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Okamoto, D. Krainc, K. Sherman, and S. A. Lipton Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation PNAS, June 13, 2000; (2000) 130502697. [Abstract] [Full Text] |
||||
![]() |
X. Zhou, V. M. Richon, R. A. Rifkind, and P. A. Marks Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5 PNAS, February 1, 2000; 97(3): 1056 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blaeser, N. Ho, R. Prywes, and T. A. Chatila Ca2+-dependent Gene Expression Mediated by MEF2 Transcription Factors J. Biol. Chem., January 7, 2000; 275(1): 197 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Naya, C Wu, J. Richardson, P Overbeek, and E. Olson Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene Development, January 5, 1999; 126(10): 2045 - 2052. [Abstract] [PDF] |
||||
![]() |
I. S. Skerjanc, H. Petropoulos, A. G. Ridgeway, and S. Wilton Myocyte Enhancer Factor 2C and Nkx2-5 Up-regulate Each Other's Expression and Initiate Cardiomyogenesis in P19 Cells J. Biol. Chem., December 25, 1998; 273(52): 34904 - 34910. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meierhans and R. K. Allemann The N-terminal Methionine Is a Major Determinant of the DNA Binding Specificity of MEF-2C J. Biol. Chem., October 2, 1998; 273(40): 26052 - 26060. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Hahm and L. E. Eiden Five Discrete Cis-active Domains Direct Cell Type-specific Transcription of the Vasoactive Intestinal Peptide (VIP) Gene J. Biol. Chem., July 3, 1998; 273(27): 17086 - 17094. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Thai, S. Guruswamy, K. T. Cao, J. E. Pessin, and A. L. Olson Myocyte Enhancer Factor 2 (MEF2)-Binding Site Is Required for GLUT4 Gene Expression in Transgenic Mice. REGULATION OF MEF2 DNA BINDING ACTIVITY IN INSULIN-DEFICIENT DIABETES J. Biol. Chem., June 5, 1998; 273(23): 14285 - 14292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Katoh, J. D. Molkentin, V. Dave, E. N. Olson, and M. Periasamy MEF2B Is a Component of a Smooth Muscle-specific Complex That Binds an A/T-rich Element Important for Smooth Muscle Myosin Heavy Chain Gene Expression J. Biol. Chem., January 16, 1998; 273(3): 1511 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Black, J. D. Molkentin, and E. N. Olson Multiple Roles for the MyoD Basic Region in Transmission of Transcriptional Activation Signals and Interaction with MEF2 Mol. Cell. Biol., January 1, 1998; 18(1): 69 - 77. [Abstract] [Full Text] |
||||
![]() |
M. P. Allen, M. Xu, C. Zeng, S. A. Tobet, and M. E. Wierman Myocyte Enhancer Factors-2B and -2C Are Required for Adhesion Related Kinase Repression of Neuronal Gonadotropin Releasing Hormone Gene Expression J. Biol. Chem., December 8, 2000; 275(50): 39662 - 39670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Okamoto, D. Krainc, K. Sherman, and S. A. Lipton Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation PNAS, June 20, 2000; 97(13): 7561 - 7566. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |